Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05458297 |
|---|---|
| Brief Title: | A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) |
| First Submitted : | July 11, 2022 |
| First Submitted that Met QC Criteria : | July 11, 2022 |
| First Posted : | July 14, 2022 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 10, 2024 |